| Title |
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|
|---|---|
| Published in |
Journal of Clinical Oncology, April 2014
|
| DOI | 10.1200/jco.2013.54.0914 |
| Pubmed ID | |
| Authors |
Dawn L Hershman, Christina Lacchetti, Robert H Dworkin, Ellen M Lavoie Smith, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Patrick Gavin, Antoinette Lavino, Maryam B Lustberg, Judith Paice, Bryan Schneider, Mary Lou Smith, Tom Smith, Shelby Terstriep, Nina Wagner-Johnston, Kate Bak, Charles L Loprinzi |
| Abstract |
To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) in adult cancer survivors. |
X Demographics
The data shown below were collected from the profiles of 70 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 26% |
| United Kingdom | 5 | 7% |
| Japan | 4 | 6% |
| Australia | 3 | 4% |
| Spain | 3 | 4% |
| Mexico | 2 | 3% |
| Belgium | 1 | 1% |
| Netherlands | 1 | 1% |
| Canada | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 29 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 66% |
| Practitioners (doctors, other healthcare professionals) | 15 | 21% |
| Scientists | 7 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 777 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 4 | <1% |
| United States | 3 | <1% |
| Brazil | 2 | <1% |
| Canada | 2 | <1% |
| Spain | 2 | <1% |
| Italy | 1 | <1% |
| Mexico | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Germany | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 759 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 120 | 15% |
| Student > Master | 95 | 12% |
| Other | 83 | 11% |
| Student > Doctoral Student | 62 | 8% |
| Student > Postgraduate | 61 | 8% |
| Other | 199 | 26% |
| Unknown | 157 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 289 | 37% |
| Pharmacology, Toxicology and Pharmaceutical Science | 71 | 9% |
| Nursing and Health Professions | 63 | 8% |
| Agricultural and Biological Sciences | 44 | 6% |
| Neuroscience | 39 | 5% |
| Other | 81 | 10% |
| Unknown | 190 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 96. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2024.
All research outputs
#439,827
of 25,413,176 outputs
Outputs from Journal of Clinical Oncology
#881
of 22,076 outputs
Outputs of similar age
#3,732
of 240,613 outputs
Outputs of similar age from Journal of Clinical Oncology
#12
of 295 outputs
Altmetric has tracked 25,413,176 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,076 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,613 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 295 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.